OCT 11, 2019 3:42 PM PDT

Blood test to detect brain cancer

Research published recently in the journal Nature Communications, a new study details the potential of a blood test that is capable of identifying brain cancer with 87% accuracy. The study was led by Dr. Matthew J. Baker, a reader in the Department of Pure and Applied Chemistry at the University of Strathclyde in Glasgow, United Kingdom.

Brain cancer is a devastating diagnosis to receive, as it comes with a less than 33% chance of a five-year survival rate. However, even getting to the point of receiving a diagnosis is a challenge, as linking the nonspecific symptoms that a brain tumor presents to the actual disease poses quite an obstacle for doctors.

Study co-author Dr. Paul Brennan, who is a senior clinical lecturer and consultant neurosurgeon at the University of Edinburgh in the U.K., commented, "Diagnosing brain tumors is difficult, leading to delays and frustration for lots of [people]. The problem is that symptoms of brain tumor are quite nonspecific, such as headache, or memory problems. It can be difficult for doctors to tell which people are most likely to have a brain tumor.”

In addition to this, the diagnostic tools that we have in place currently are expensive and invasive, making the possibility of a blood test evermore crucial. Dr. Baker says, "This is the first publication of data from our clinical feasibility study, and it is the first demonstration that our blood test works in the clinic."

Brain tumors can be difficult to detect because of nonspecific symptoms like headaches. Photo: Pixabay

In conducting the study, the researchers used a technique called attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy combined with machine learning technology to identify and detect brain cancer. Out of 104 people, the test had an 87% accuracy detection rate.

"With this new test, we have shown that we can help doctors quickly identify which [people] with these nonspecific symptoms should be prioritized for urgent brain imaging," says Dr. Brennan. "This," he adds, "means a more rapid diagnosis for people with a brain tumor and quicker access to treatment."

Sources: Medical News Today, Nature Communications

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
OCT 05, 2020
Health & Medicine
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
OCT 05, 2020
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
Even with the best anti-nausea medications one in three patients receiving chemotherapy experiences vomiting, and about ...
OCT 16, 2020
Cancer
Chronic jet lag raises cancer risk
OCT 16, 2020
Chronic jet lag raises cancer risk
We all know how horrible it feels to have a bad night of sleep. That feeling is only intensified with jet lag because ou ...
OCT 22, 2020
Cancer
Cancer cells don't like crowded spaces
OCT 22, 2020
Cancer cells don't like crowded spaces
Researchers collaborating from St. Anna Children's Cancer Research Institute Vienna, King's College London, Inst ...
OCT 26, 2020
Chemistry & Physics
Fighting mesothelioma with gold nanotubes
OCT 26, 2020
Fighting mesothelioma with gold nanotubes
New research published in the journal Small details how gold nanotubes could be used to treat mesothelioma cancer. ...
NOV 06, 2020
Drug Discovery & Development
Anti-depressant Shows Promise in Treating Childhood Cancer
NOV 06, 2020
Anti-depressant Shows Promise in Treating Childhood Cancer
Researchers from Sweden and the US have found that a commonly prescribed antidepressant may help stop the growth of a ca ...
NOV 22, 2020
Cancer
Unmet social needs influence patient breast health care
NOV 22, 2020
Unmet social needs influence patient breast health care
New research to be presented at the annual meeting of the Radiological Society of North America will report on the breas ...
Loading Comments...